Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.68
$0.023.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 187.90% | -19.84% | 244.71% | 72.44% | 38.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 56.90% | -25.71% | 163.75% | 113.11% | 38.53% |
| Operating Income | -56.90% | 25.71% | -163.75% | -113.11% | -38.53% |
| Income Before Tax | -63.58% | 37.97% | -82.48% | -76.37% | 2.56% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -63.58% | 37.97% | -82.48% | -76.37% | 2.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -63.58% | 37.97% | -82.48% | -76.37% | 2.56% |
| EBIT | -56.90% | 25.71% | -163.75% | -113.11% | -38.53% |
| EBITDA | -40.78% | 25.73% | -163.91% | -113.33% | -38.61% |
| EPS Basic | 88.37% | 97.36% | 86.36% | 63.57% | 60.31% |
| Normalized Basic EPS | 86.85% | 96.71% | 86.43% | 62.08% | 61.57% |
| EPS Diluted | 90.52% | 97.36% | 86.36% | 63.57% | 51.19% |
| Normalized Diluted EPS | 86.85% | 96.71% | 86.43% | 62.08% | 61.57% |
| Average Basic Shares Outstanding | 1,306.75% | 2,251.26% | 1,237.41% | 384.34% | 145.51% |
| Average Diluted Shares Outstanding | 1,306.75% | 2,251.26% | 1,237.41% | 384.34% | 145.51% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |